Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides [NA]

View source ↗

Summary

A Chung Shan Medical University study is evaluating blood glucose-regulating effects of Momordica charantia peptides in people with prediabetes; the trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Momordica charantia peptides

Snippet

Sponsor: Chung Shan Medical University | Conditions: People With Prediabetic | NA | Status: RECRUITING